GlycoSeLect Ltd

Biotechnology ResearchDublin 9, Ireland2-10 Employees

GlycoSeLect specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs), innovative technology for the analysis and purification of glycosylated biomolecules. RPLs have a broad spectrum of applications across the life sciences in:

•    Basic R&D – Glycobiology & Glycoproteomics.
•    Biomarker Discover & Biomedical Diagnostics.
•    The Biopharmaceutical Industry.
•    Vaccines
•    Cosmetics

GlycoSeLect's Recombinant Prokaryotic Lectins (RPLs) present significant advantages over existing commercially available lectins products including:
    
    •    Simplified, rapid & cost effective production through recombinant expression in Escherichia coli.
    •    High purity & consistent performance.
    •    Genetically enhanced glycan binding properties (specificity & affinity).
    •    Scalable production facilitating utilization for large scale applications.

For more information please visit our website at www.glycoselect.com

Sign up for free to view info

Email Format Employee directory